Table 4.

Summary of RR measurement algorithm performance across different demographic sub-group.

Demographic variables		Reference datapoints	Measured datapoints	MAE	DR (%)
RR (BrPM)	5–15	14,360	13,235	1.54	92.17
	15–25	50,271	46,872	1.21	93.24
	25–35	3536	3065	1.65	86.68
	35–45	126	121	1.58	96.03
	> 45	49	48	1.31	97.96
Age (years)	18–24	13,825	13,075	1.27	94.58
	24–30	17,614	16,645	1.23	94.5
	30–36	11,336	10,928	1.12	96.4
	36–42	6893	5828	1.54	84.55
	42–48	3751	3247	1.37	86.56
	>=48	14,830	13,539	1.4	91.29
Gender	Female	29,667	27,300	1.22	92.02
	Male	38,675	36,041	1.34	93.19
BMI (kg/m²)	< 18.5	4765	4612	1.16	96.79
	18.5–24.9	35,690	32,665	1.26	91.52
	25–45	27,794	25,985	1.35	93.49
Race/ethnicity	Asian-American	1122	1046	1.47	93.23
	Black/ African American	378	348	1.44	92.06
	Indian	62,200	57,612	1.24	92.62
	Mixed	241	230	1.81	95.44
	White/Caucasian/unknown	4401	4105	1.92	93.27
Study subjects	Healthy Volunteers	42,413	40,214	1.21	94.82
	ICU Subjects	7071	6518	1.09	92.18
	Sleep Apnea Subjects	2977	2846	1.15	95.6
	Ward Patients	15,881	13,763	1.66	86.66
Comorbidities	Hypertension	5788	4759	1.36	82.22
	Diabetes	5677	4781	1.95	84.22
	Cardiovascular Disease	2723	2314	2.14	84.98
	Obesity	2655	2262	2.04	85.2
	COPD	1713	1342	1.33	78.34
	Apnea	2959	2834	1.13	95.78
	Hypothyroidism	1234	1066	1.24	86.39
	Hyperthyroidism	1769	1455	1.37	82.25
	Trauma	1372	1352	0.75	98.54
	Hemorrhage	1194	1145	0.86	95.9
	Others	4296	3737	1.35	86.99
	No Comorbidities reported	50,214	47,285	1.25	94.17